The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase III post-operative trial of platinum-based chemotherapy (P) versus capecitabine (C) in patients (pts) with residual triple-negative breast cancer (TNBC) following neoadjuvant chemotherapy (NAC): ECOG-ACRIN EA1131
 
Ingrid A. Mayer
Consulting or Advisory Role - Abbvie; AstraZeneca; Blueprint Medicines; Cyclacel; Genentech; GlaxoSmithKline; Immunomedics; Lilly; Macrogenics; Novartis; Pfizer; Puma Biotechnology; Seagen
Research Funding - Genentech (Inst); Novartis (Inst); Pfizer (Inst)
 
Fengmin Zhao
No Relationships to Disclose
 
Carlos L. Arteaga
Leadership - American Association for Cancer Research
Stock and Other Ownership Interests - Provista Diagnostics; Y-Trap Inc.
Consulting or Advisory Role - Athenex; Clovis Oncology; Daiichi Sankyo; G1 Therapeutics; H3 Biomedicine; Immunomedics; Lilly; Merck; Novartis; Origimed; Petra Pharma; Puma Biotechnology; Radius Health; Sanofi; Symphogen; Taiho Pharmaceutical; Third Rock Ventures
Research Funding - Bayer; Lilly; Pfizer; Puma Biotechnology; Radius Health; Takeda
Other Relationship - Susan G. Komen for the Cure
 
William Fraser Symmans
Stock and Other Ownership Interests - Delphi Diagnostics; Eiger BioPharmaceuticals; ISIS Pharmaceuticals; Nuvera Biosciences
Consulting or Advisory Role - Almac Diagnostics; Merck
Patents, Royalties, Other Intellectual Property - Intellectual property; Intellectual Property (expired)
Travel, Accommodations, Expenses - Luminex; Merck
(OPTIONAL) Uncompensated Relationships - Delphi Diagnostics
 
Ben Ho Park
Leadership - Loxo
Stock and Other Ownership Interests - Celcuity; Loxo
Honoraria - AstraZeneca
Consulting or Advisory Role - Casdin Capital; Celcuity; Foundation Medicine; H3 Biomedicine; Horizon Discovery; Jackson Laboratory for Genomic Medicine; Lilly; Loxo; Pathovax; Sermonix Pharmaceuticals
Research Funding - Abbvie; GE Healthcare; Lilly; Pfizer
Patents, Royalties, Other Intellectual Property - Royalties paid through inventions at Johns Hopkins University by Horizon Discovery LTD
Travel, Accommodations, Expenses - Lilly; Loxo
(OPTIONAL) Uncompensated Relationships - Tempus
 
Brian Leslie Burnette
No Relationships to Disclose
 
Amye Juliet Tevaarwerk
Other Relationship - Epic Systems (I)
 
Sofia F. Garcia
No Relationships to Disclose
 
Karen L. Smith
Stock and Other Ownership Interests - Abbott Laboratories (I); Abbvie (I)
Honoraria - ASiM CME
Research Funding - Pfizer (Inst); Pfizer (Inst)
 
Erica L. Mayer
Consulting or Advisory Role - AstraZeneca; Eisai; Lilly; Novartis; Sanofi
Research Funding - Pfizer (Inst)
 
William M. Sikov
Honoraria - UpToDate
Speakers' Bureau - Daiichi Sankyo; Eisai; Lilly; Seagen
 
Eve T. Rodler
No Relationships to Disclose
 
Lynne I. Wagner
Stock and Other Ownership Interests - Gilead Sciences (I); Johnson & Johnson (I); Lilly (I)
Consulting or Advisory Role - Athenex; Celgene
Travel, Accommodations, Expenses - Celgene
 
Angela DeMichele
Consulting or Advisory Role - Context Therapeutics; Pfizer (I)
Research Funding - Calithera Biosciences (Inst); Genentech (Inst); Menarini Silicon Biosystems (Inst); Pfizer (Inst)
 
Joseph A. Sparano
Stock and Other Ownership Interests - Metastat
Consulting or Advisory Role - Adgero Biopharmaceuticals; AstraZeneca; BMSi; Cardinal Health; Celgene; Celldex; CStone Pharmaceuticals; Daiichi Sankyo; Epic Sciences; Genentech/Roche; GlaxoSmithKline; Juno Therapeutics; Lilly; Merrimack; Novartis; Pfizer; Pfizer; Prescient Therapeutics
Speakers' Bureau - Certara Inc; Eisai
Research Funding - Deciphera (Inst); Genentech/Roche (Inst); Merck (Inst); Merrimack (Inst); Novartis (Inst); Novartis (Inst); Olema Pharmaceuticals (Inst); Prescient Therapeutics (Inst); Radius Health (Inst)
Travel, Accommodations, Expenses - Adgero Biopharmaceuticals; AstraZeneca; Menarini Silicon Biosystems; Myriad Genetics; Pfizer; Rhenium Medical; Roche/Genentech
 
Antonio C. Wolff
Consulting or Advisory Role - Ionis Pharmaceuticals
Research Funding - Biomarin (Inst); Celldex (Inst)
Patents, Royalties, Other Intellectual Property - Antonio Wolff has been named as inventor on one or more issued patents or pending patent applications relating to methylation in breast cancer, and has assigned his rights to JHU, and participates in a royalty sharing agreement with JHU.
 
Kathy Miller
Consulting or Advisory Role - Athenex; Genentech/Roche; Merck
Research Funding - Astex Pharmaceuticals (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst)